Ryan J. Watts Denali Therapeutics Inc. (DNLI) insider trading activity

DNLI Quotes by TradingView

Ryan J. Watts is President and CEO of Denali Therapeutics Inc.. Currently has a direct ownership of 238,067 shares of DNLI, which is worth approximately $5.15 Million. The most recent transaction as insider was on Feb 13, 2024, when has been sold 9,589 shares (Common Stock) at a price of $17.29 per share, resulting in proceeds of $165,793. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 238K
0% 3M change
2.64% 12M change
Total Value Held $5.15 Million

Ryan J. Watts Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2024
SELL
Open market or private sale
$165,793 $17.29 p/Share
9,589 Reduced 3.87%
238,067 Common Stock
Jan 03 2024
BUY
Grant, award, or other acquisition
-
89,520 Added 24.7%
272,957 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
82,240 Added 26.18%
231,934 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
$526,373 $7.44 p/Share
70,749 Added 21.35%
260,640 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
62,000 Added 22.49%
213,691 Common Stock
RJW

Ryan J. Watts

President and CEO
South San Francisco, CA

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNLI